Cleerly to Present on AI-Enabled Heart Disease Solutions at SCCT 2023
Cleerly to Present on AI-Enabled Heart Disease Solutions at SCCT 2023 Executives to discuss Cleerly’s end-to-end solution for precision heart imaging...
Cleerly is aware of the lawsuit filed by Heartflow. We are confident in our extensive and well-established intellectual property portfolio and the originality of our technology.
Cleerly has published landmark clinical science that has redefined how cardiovascular disease is understood and treated, which has formed the basis of our novel technologies that provide physicians with actionable insights into their patients’ heart health.
Cleerly was founded on a mission to create a world without heart attacks, and we have never been more focused in our mission and committed to the patients and physicians who count on us.
For any questions, please reach out to press@cleerlyhealth.com
Cleerly to Present on AI-Enabled Heart Disease Solutions at SCCT 2023 Executives to discuss Cleerly’s end-to-end solution for precision heart imaging...
Cenegenics’ U.S. locations now offering Cleerly’s AI-enabled approach to personalized heart care
L.A. area cardiologists leverage AI-enabled approach to develop personalized heart care diagnoses and treatment plans Denver – May 3, 2023 --...
Krissy Wright joins as CFO and Sandra Statz as EVP of Regulatory Affairs to Support Company’s Mission to Create a World Without Heart Attacks New...